Metastatic prostate cancer Clinical Trials in Lancaster, PA
As of June 2026, 1 paid clinical trial is recruiting for Metastatic prostate cancer in Lancaster, Pennsylvania. Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Lancaster
Filter results
1 clinical trial for Metastatic prostate cancer
·Clear filters·↓ Download CSVAbout research studies in Lancaster
Lancaster has approximately 82 recruiting research studies across a wide range of therapeutic areas. Pennsylvania hosts UPenn's Perelman School of Medicine and Children's Hospital of Philadelphia — pioneers in CAR-T cell therapy — alongside UPMC, Thomas Jefferson University, and Penn State Hershey.
Top Research Study Locations in Lancaster
Researchers run research studies in Lancaster, PA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Lancaster General Hospital | Heart Failure, Abdominal Wound Dehiscence, Advanced Cancer | 15 |
| Lancaster General Ann B Barshinger Cancer Institute | Breast Cancer, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 10 |
| Keystone Urology Specialists | Non-Muscle Invasive Bladder Neoplasms, FGFR Gene Alterations, FGFR Gene Amplification | 9 |
| Lancaster General Health | Cancer, Cardiovascular Disease and Lipoprotein(a), Hypertension | 4 |
| Lancaster General Hospital - Ann B Barshinger Cancer Institute | Neoplasm Metastasis, Breast Neoplasms, Carcinoma, Transitional Cell | 4 |
| Penn Medicine Lancaster General Health | Burnout, Professional, Cardiovascular Diseases, Functional Mitral Regurgitation | 4 |
| Conestoga Eye | Amblyopia | 3 |
| Amish Research Clinic | Diabetes Type 2, Hyperglycemia, Obesity | 2 |
| Penn Medicine Lancaster General | AV Block, Heart Failure, Heart Failure With Reduced Ejection Fraction | 2 |
| US Digestive Health | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| University of Maryland Amish Research Clinic | Diabetes, Ethics, Familial Hypercholesterolemia | 2 |
| Hospice and Community Care | Advance Care Planning, Advance Directives, Chronic Illness | 1 |
| Advanced Surgery Center of Lancaster | Lumbar Spinal Stenosis | 1 |
| Ann B Barshinger Cancer Institute | Ovarian Cancer | 1 |
| Ann B. Barshinger Cancer Institute | Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 1 |
| Cardiology Care for Children | Cardiomyopathy | 1 |
| Clinical Trial Site | Transthyretin Amyloidosis With Cardiomyopathy | 1 |
| Heart Grp_ Lancaster Gen Hlth | Heart Failure | 1 |
| Lancaster Gen Health | Lumbar Spinal Stenosis | 1 |
| Lancaster General Health - Ann B. Barshinger Cancer Institute | Cervical Cancer, Endometrial Cancer, Uterine Cancer | 1 |
| Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068) | Non Small Cell Lung Cancer | 1 |
| Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0111) | Non-small Cell Lung Cancer | 1 |
| Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0134) | Non-small Cell Lung Cancer | 1 |
| Local Institution - 0288 | Non-Small Cell Lung Cancer (NSCLC) | 1 |
| Local Institution - 0301 | Pancreatic Ductal Adenocarcinoma | 1 |
Active & Upcoming Studies in Lancaster (2026)
Recruiting trials in Lancaster grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (37 active studies)
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) · Phase 3 · Bristol-Myers Squibb
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract · Phase 3 · Eli Lilly and Company
Cardiovascular (12 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- ELEVATE-HFpEF Clinical Study · Medtronic Cardiac Rhythm and Heart Failure
Diabetes & metabolic (3 active studies)
- Pharmacogenetics of Response to Sitagliptin (PRS) · Phase 4 · University of Maryland, Baltimore
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
- MyStroke for Stroke Survivors and Caregivers · University of Pennsylvania
Pediatric (1 active study)
- Vancomycin Reduction Practices (VRP) in the NICU · Children's Hospital of Philadelphia
Common conditions studied in Lancaster
- Heart Failure (7 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Amblyopia (3 active studies). Recruiting Amblyopia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Neoplasm Metastasis (3 active studies). Recruiting Neoplasm Metastasis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-small Cell Lung Cancer (3 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Prostate Cancer (3 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
Leading research sponsors in Lancaster
- Bristol-Myers Squibb
- NRG Oncology
- Abramson Cancer Center at Penn Medicine
- University of Maryland, Baltimore
- Eli Lilly and Company
Local regulations and guidelines
Clinical trials in Pennsylvania are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Pennsylvania research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Lancaster. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Lancaster
Hipa.ai aggregates every recruiting study in Lancaster from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Lancaster?
There are approximately 82 recruiting clinical trials in Lancaster, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lancaster pay participants?
Most recruiting trials in Lancaster compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lancaster?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lancaster?
The most common conditions under active study in Lancaster include Heart Failure (7), Amblyopia (3), Breast Cancer (3), Neoplasm Metastasis (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lancaster?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lancaster on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lancaster?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lancaster?
Recruiting research sites in Lancaster include Lancaster General Hospital, Lancaster General Ann B Barshinger Cancer Institute, Keystone Urology Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lancaster right now?
The largest active categories in Lancaster are Cancer & tumors (37), Cardiovascular (12), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.